Monkeypox Has the Potential to Mutate and Resist Antiviral Treatment, FDA Warns

The rapid mutation of the mpox virus is a concerning development, as it could lead to resistance against existing antiviral treatments. If this trend continues, it may pose a significant challenge for public health efforts, making the virus harder to control and treat. This underscores the urgent need for continuous genomic surveillance, research into new treatment options, and expanded vaccination programs to stay ahead of the virus. Additionally, global collaboration is crucial to ensure that lower-income countries, which often bear the brunt of such outbreaks, receive adequate resources and support to contain the spread.